YaoGeJu

Company directoryChina company filings

Shandong Lukang Group Saite Co., Ltd.

As of 17 November 2026, for the company name Shandong Lukang Group Saite Co., Ltd. as recorded, 10 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 58 records, across 38 drug names; since 21 August 2026, the records list Accepted: 2 applications, Notification delivery: 2 applications; the chemical-drug catalogue lists 26 active records with this name as holder; 2 active API registrations list this name as first registered company; 9 further acceptance records name it after the first applicant.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/17
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/17.

Drug filings

58 acceptance records as first applicant, grouped into 38 source drug names. Source data as of 2026/11/17.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Dapagliflozin Tablets 2 records · Latest accepted 2026/08/28

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602153Generic2026/08/28Shandong Lukang Group Saite Co., Ltd.CDE ↗
CYHS2602152Generic2026/08/28Shandong Lukang Group Saite Co., Ltd.CDE ↗
Ilaprazole Enteric-coated Tablets 2 records · Latest accepted 2026/08/20

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602077Generic2026/08/20Shandong Lukang Group Saite Co., Ltd.; Jilin Si Huan Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHS2501362Generic2025/04/09Shandong Lukang Group Saite Co., Ltd.; Jilin Si Huan Pharmaceutical Co., Ltd. romanizedCDE ↗
Azithromycin for Suspension 1 records · Latest accepted 2026/08/11

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601965Generic2026/08/11Shandong Lukang Group Saite Co., Ltd.CDE ↗
Crisaborole Ointment 1 records · Latest accepted 2026/07/24

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2601424Supplement2026/07/24Shandong Lukang Group Saite Co., Ltd.; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanizedCDE ↗
Nifedipine Controlled-release Tablets 1 records · Latest accepted 2026/06/23

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601467Generic2026/06/23Shandong Lukang Group Saite Co., Ltd.; Yan Tai Lu Yin Pharma Co., Ltd. romanizedCDE ↗
Vardenafil Hydrochloride Tablets 3 records · Latest accepted 2026/05/08

Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2600870Supplement2026/05/08Shandong Lukang Group Saite Co., Ltd.; Anhui Tai En Kang Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHB2500808Supplement2025/04/24Shandong Lukang Group Saite Co., Ltd.; Anhui Tai En Kang Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHB2500807Supplement2025/04/24Shandong Lukang Group Saite Co., Ltd.; Anhui Tai En Kang Pharmaceutical Co., Ltd. romanizedCDE ↗
Sildenafil Citrate Tablets 3 records · Latest accepted 2026/03/02

Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2600420Supplement2026/03/02Shandong Lukang Group Saite Co., Ltd.; Anhui Tai En Kang Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHB2600419Supplement2026/03/02Shandong Lukang Group Saite Co., Ltd.; Anhui Tai En Kang Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHB2600418Supplement2026/03/02Shandong Lukang Group Saite Co., Ltd.; Anhui Tai En Kang Pharmaceutical Co., Ltd. romanizedCDE ↗
诺氟沙星胶囊 · No verified English name 1 records · Latest accepted 2025/12/17

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2550400Supplement2025/12/17Shandong Lukang Group Saite Co., Ltd.CDE ↗
Letermovir Injection 1 records · Latest accepted 2025/11/01

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503850Generic2025/11/01Shandong Lukang Group Saite Co., Ltd.; Chengdu Tong De Pharma Co., Ltd. romanizedCDE ↗
Ketorolac Tromethamine Injection 1 records · Latest accepted 2025/10/24

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2502202Supplement2025/10/24Shandong Lukang Group Saite Co., Ltd.; Sichuan Xin Si Dun Pharmaceutical Co., Ltd. romanizedCDE ↗
Methocarbamol Injection 1 records · Latest accepted 2025/08/02

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2501524Supplement2025/08/02Shandong Lukang Group Saite Co., Ltd.; Shanxi Pu De Pharma Co., Ltd. romanizedCDE ↗
Amikacin Sulfate injection 1 records · Latest accepted 2025/07/18

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2550260Supplement2025/07/18Shandong Lukang Group Saite Co., Ltd.CDE ↗
Baricitinib Tablets 1 records · Latest accepted 2025/07/16

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502558Generic2025/07/16Shandong Lukang Group Saite Co., Ltd.; Jiangsu Hua Yang Pharmaceutical Co., Ltd. romanizedCDE ↗
托吡酯口服溶液 · No verified English name 1 records · Latest accepted 2025/06/12

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502105Generic2025/06/12Shandong Lukang Group Saite Co., Ltd.; Hunan Jiudian Pharmaceutical Co., LtdCDE ↗
Sacubitril Valsartan Sodium Tablets 3 records · Latest accepted 2025/04/12

Generic · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501417Generic2025/04/12Shandong Lukang Group Saite Co., Ltd.CDE ↗
CYHS2501416Generic2025/04/12Shandong Lukang Group Saite Co., Ltd.CDE ↗
CYHS2501415Generic2025/04/12Shandong Lukang Group Saite Co., Ltd.CDE ↗
Iron Proteinsuccinylate Oral Solution 1 records · Latest accepted 2025/04/10

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501385Generic2025/04/10Shandong Lukang Group Saite Co., Ltd.; Hua Yi Tai Kang Pharma Co., Ltd. romanizedCDE ↗
Rosuvastatin Calcium and Ezetimibe Tablets (I) 1 records · Latest accepted 2025/04/08

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501321Generic2025/04/08Shandong Lukang Group Saite Co., Ltd.; Rui Hua (Zhong Shan) Pharmaceutical Co., Ltd. romanizedCDE ↗
Linagliptin Tablets 1 records · Latest accepted 2024/09/26

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2401565Supplement2024/09/26Shandong Lukang Group Saite Co., Ltd.; Shandong Lang Nuo Pharmaceutical Co., Ltd. romanizedCDE ↗
Phloroglucinol Injection 1 records · Latest accepted 2024/09/14

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2401485Supplement2024/09/14Shandong Lukang Group Saite Co., Ltd.; Shanxi Wei Qi Da Guang Ming Pharmaceutical Co., Ltd. romanizedCDE ↗
Dapoxetine Hydrochloride Tablets 4 records · Latest accepted 2024/09/02

Supplement · 4

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2401372Supplement2024/09/02Shandong Lukang Group Saite Co., Ltd.; Jiangxi Shimei Pharmaceutical Co., LtdCDE ↗
CYHB2401371Supplement2024/09/02Shandong Lukang Group Saite Co., Ltd.; Jiangxi Shimei Pharmaceutical Co., LtdCDE ↗
CYHB2400880Supplement2024/06/25Shandong Lukang Group Saite Co., Ltd.; Jiangxi Shimei Pharmaceutical Co., LtdCDE ↗
CYHB2400879Supplement2024/06/25Shandong Lukang Group Saite Co., Ltd.; Jiangxi Shimei Pharmaceutical Co., LtdCDE ↗
Minoxidil Liniment 2 records · Latest accepted 2024/08/10

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402593Generic2024/08/10Shandong Lukang Group Saite Co., Ltd.CDE ↗
CYHS2402592Generic2024/08/10Shandong Lukang Group Saite Co., Ltd.CDE ↗
Finasteride Tablets 2 records · Latest accepted 2024/07/19

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402276Generic2024/07/19Shandong Lukang Group Saite Co., Ltd.CDE ↗
CYHS2402275Generic2024/07/19Shandong Lukang Group Saite Co., Ltd.CDE ↗
Azithromycin Tablets 1 records · Latest accepted 2024/06/01

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450313Supplement2024/06/01Shandong Lukang Group Saite Co., Ltd.CDE ↗
Cimetidine Injection 1 records · Latest accepted 2023/12/26

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350969Supplement2023/12/26Shandong Lukang Group Saite Co., Ltd.CDE ↗
Haloperidol Lactate Injection 1 records · Latest accepted 2023/11/11

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350827Supplement2023/11/11Shandong Lukang Group Saite Co., Ltd.CDE ↗
Tadalafil Tablets 4 records · Latest accepted 2023/09/15

Supplement · 4

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2302097Supplement2023/09/15Shandong Lukang Group Saite Co., Ltd.CDE ↗
CYHB2301204Supplement2023/05/24Shandong Lukang Group Saite Co., Ltd.CDE ↗
CYHB2301203Supplement2023/05/24Shandong Lukang Group Saite Co., Ltd.CDE ↗
CYHB2101873Supplement2021/09/22Shandong Lukang Group Saite Co., Ltd.CDE ↗
Esmolol Hydrochloride Injection 1 records · Latest accepted 2023/09/02

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350666Supplement2023/09/02Shandong Lukang Group Saite Co., Ltd.CDE ↗
腺苷钴胺胶囊 · No verified English name 1 records · Latest accepted 2023/05/17

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2301332Generic2023/05/17Shandong Lukang Group Saite Co., Ltd.CDE ↗
Moxifloxacin Hydrochloride And Sodium Chloride Injection 1 records · Latest accepted 2023/04/05

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2300979Generic2023/04/05Shandong Lukang Group Saite Co., Ltd.CDE ↗
Doxofylline Injection 1 records · Latest accepted 2023/02/23

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2300616Generic2023/02/23Shandong Lukang Group Saite Co., Ltd.CDE ↗
Ambroxol Hydrochloride Injection 2 records · Latest accepted 2022/08/12

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250495Supplement2022/08/12Shandong Lukang Group Saite Co., Ltd.CDE ↗
CYHB2250494Supplement2022/08/12Shandong Lukang Group Saite Co., Ltd.CDE ↗
硝苯地平缓释片(I) · No verified English name 1 records · Latest accepted 2022/07/18

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250444Supplement2022/07/18Shandong Lukang Group Saite Co., Ltd.CDE ↗
Ornidazole Tablets 2 records · Latest accepted 2022/06/20

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250372Supplement2022/06/20Shandong Lukang Group Saite Co., Ltd.CDE ↗
CYHB2250371Supplement2022/06/20Shandong Lukang Group Saite Co., Ltd.CDE ↗
Glipizide Tablets 1 records · Latest accepted 2022/02/17

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250058Supplement2022/02/17Shandong Lukang Group Saite Co., Ltd.CDE ↗
Simvastatin Tablets 2 records · Latest accepted 2021/09/15

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150871Supplement2021/09/15Shandong Lukang Group Saite Co., Ltd.CDE ↗
CYHB2150870Supplement2021/09/15Shandong Lukang Group Saite Co., Ltd.CDE ↗
Gliclazide Modified Release Tablets 1 records · Latest accepted 2021/06/18

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150673Supplement2021/06/18Shandong Lukang Group Saite Co., Ltd.CDE ↗
Isosorbide Mononitrate Extended-Release Tablets 1 records · Latest accepted 2021/06/17

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150665Supplement2021/06/17Shandong Lukang Group Saite Co., Ltd.CDE ↗
Atorvastatin Calcium Tablets 2 records · Latest accepted 2021/05/21

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2101168Generic2021/05/21Shandong Lukang Group Saite Co., Ltd.CDE ↗
CYHS2101167Generic2021/05/21Shandong Lukang Group Saite Co., Ltd.CDE ↗

Changes in the last 90 days

4 events from 2026/08/21 to 2026/11/18. CDE data as of 2026/11/17; NMPA data as of 2026/11/17.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Accepted: 2 applicationsNotification delivery: 2 applications

  1. 2026/10/21Notification delivery

    Sacubitril Valsartan Sodium Tablets

    CYHS2501417

    Fact date: 2026/10/21 (Publication date) · Publication date: 2026/10/21 · Date added to this site: 2026/11/03

    Notification delivered; the specific outcome remains to be checked.

    View source · Table row 6 ↗
  2. 2026/10/21Notification delivery

    Sacubitril Valsartan Sodium Tablets

    CYHS2501416

    Fact date: 2026/10/21 (Publication date) · Publication date: 2026/10/21 · Date added to this site: 2026/11/03

    Notification delivered; the specific outcome remains to be checked.

    View source · Table row 5 ↗
  3. 2026/08/28Accepted

    Dapagliflozin Tablets

    CYHS2602153

    Fact date: 2026/08/28 · Date added to this site: 2026/10/21

    View source ↗
  4. 2026/08/28Accepted

    Dapagliflozin Tablets

    CYHS2602152

    Fact date: 2026/08/28 · Date added to this site: 2026/10/21

    View source ↗

Under review

10 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/17.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Dapagliflozin Tablets CYHS2602153Generic2026/08/28Shandong Lukang Group Saite Co., Ltd.CDE ↗
Dapagliflozin Tablets CYHS2602152Generic2026/08/28Shandong Lukang Group Saite Co., Ltd.CDE ↗
Ilaprazole Enteric-coated Tablets CYHS2602077Generic2026/08/20Shandong Lukang Group Saite Co., Ltd.; Jilin Si Huan Pharmaceutical Co., Ltd. romanizedCDE ↗
Azithromycin for Suspension CYHS2601965Generic2026/08/11Shandong Lukang Group Saite Co., Ltd.CDE ↗
Nifedipine Controlled-release Tablets CYHS2601467Generic2026/06/23Shandong Lukang Group Saite Co., Ltd.; Yan Tai Lu Yin Pharma Co., Ltd. romanizedCDE ↗
诺氟沙星胶囊 · No verified English name CYHB2550400Supplement2025/12/17Shandong Lukang Group Saite Co., Ltd.CDE ↗
Letermovir Injection CYHS2503850Generic2025/11/01Shandong Lukang Group Saite Co., Ltd.; Chengdu Tong De Pharma Co., Ltd. romanizedCDE ↗
Baricitinib Tablets CYHS2502558Generic2025/07/16Shandong Lukang Group Saite Co., Ltd.; Jiangsu Hua Yang Pharmaceutical Co., Ltd. romanizedCDE ↗
托吡酯口服溶液 · No verified English name CYHS2502105Generic2025/06/12Shandong Lukang Group Saite Co., Ltd.; Hunan Jiudian Pharmaceutical Co., LtdCDE ↗
Iron Proteinsuccinylate Oral Solution CYHS2501385Generic2025/04/10Shandong Lukang Group Saite Co., Ltd.; Hua Yi Tai Kang Pharma Co., Ltd. romanizedCDE ↗

Catalogue holder records

26 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/17. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Rosuvastatin Calcium and Ezetimibe Tablets (I)Shandong Lukang Group Saite Co., Ltd.Rui Hua (Zhong Shan) Pharmaceutical Co., Ltd. romanized国药准字H202650282026/06/30Generic approved under the new chemical-drug registration classificationCDE ↗
Finasteride TabletsShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H202563662025/12/22Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Finasteride TabletsShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H202563672025/12/22Generic approved under the new chemical-drug registration classificationCDE ↗
Vardenafil Hydrochloride TabletsShandong Lukang Group Saite Co., Ltd.Anhui Tai En Kang Pharmaceutical Co., Ltd. romanized国药准字H202549532025/07/29Generic approved under the new chemical-drug registration classificationCDE ↗
Azithromycin TabletsShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H200332982025/05/24Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Linagliptin TabletsShandong Lukang Group Saite Co., Ltd.Shandong Lang Nuo Pharmaceutical Co., Ltd. romanized国药准字H202532712025/01/24Generic approved under the new chemical-drug registration classificationCDE ↗
Esmolol Hydrochloride InjectionShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H200677042024/11/12Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Haloperidol Lactate InjectionShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H370240422024/10/30Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Moxifloxacin Hydrochloride And Sodium Chloride InjectionShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H202490302024/10/09Generic approved under the new chemical-drug registration classificationCDE ↗
腺苷钴胺胶囊 · No verified English nameShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H202446522024/08/05Generic approved under the new chemical-drug registration classificationCDE ↗
Tadalafil TabletsShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H202471572024/07/09Generic approved under the new chemical-drug registration classificationCDE ↗
Tadalafil TabletsShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H202471562024/07/09Generic approved under the new chemical-drug registration classificationCDE ↗
Doxofylline InjectionShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H202437772024/05/21Generic approved under the new chemical-drug registration classificationCDE ↗
Ambroxol Hydrochloride InjectionShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H202035432023/10/07Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Ambroxol Hydrochloride InjectionShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H202035422023/10/07Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Ornidazole TabletsShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H201330702023/09/11Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Ornidazole TabletsShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H201330702023/09/11Drug that passed quality-and-efficacy consistency evaluationCDE ↗
硝苯地平缓释片(I) · No verified English nameShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H200940732023/08/31Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Atorvastatin Calcium TabletsShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H202333312023/03/24Generic approved under the new chemical-drug registration classificationCDE ↗
Atorvastatin Calcium TabletsShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H202333302023/03/24Generic approved under the new chemical-drug registration classificationCDE ↗
Glipizide TabletsShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H200464712022/11/02Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Simvastatin TabletsShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H200838392022/08/23Not stated by sourceCDE ↗
Simvastatin TabletsShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H200838402022/08/23Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Isosorbide Mononitrate Extended-Release TabletsShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H200838382022/07/04Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Gliclazide Modified Release TabletsShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H200834772022/03/25Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Tinidazole TabletsShandong Lukang Group Saite Co., Ltd.Shandong Lukang Group Saite Co., Ltd.国药准字H200330902022/01/19Drug that passed quality-and-efficacy consistency evaluationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

2 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/17.

NameCompany / applicantRegistration numberStatusSource update dateView source
氯贝酸铝 · No verified English nameShandong Lukang Group Saite Co., Ltd.Y20190002054A2025/04/04CDE ↗
西洛他唑 · No verified English nameShandong Lukang Group Saite Co., Ltd.Y20190002004A—CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

9 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/17.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Levofloxacin Tablets CYHS2602280Generic2026/09/15Shandong Kang Lin Pharmaceuticals Co., Ltd. romanized; Shandong Lukang Group Saite Co., Ltd.CDE ↗
聚乙二醇钠钾散 · No verified English name CYHB2600649Supplement2026/04/01Shandong Xin Hua Lu Kang Pharmaceuticals Co., Ltd. romanized; Shandong Lukang Group Saite Co., Ltd.CDE ↗
Atorvastatin Calcium Tablets CYHB2401493Supplement2024/09/14Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.; Shandong Lukang Group Saite Co., Ltd.CDE ↗
Atorvastatin Calcium Tablets CYHB2401492Supplement2024/09/14Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.; Shandong Lukang Group Saite Co., Ltd.CDE ↗
Levofloxacin Tablets CYHS2400605Generic2024/02/09Shandong Kang Lin Pharmaceuticals Co., Ltd. romanized; Shandong Lukang Group Saite Co., Ltd.CDE ↗
Levofloxacin Tablets CYHS2400604Generic2024/02/09Shandong Kang Lin Pharmaceuticals Co., Ltd. romanized; Shandong Lukang Group Saite Co., Ltd.CDE ↗
聚乙二醇钠钾散 · No verified English name CYHS2201777Generic2022/10/19Shandong Xin Hua Lu Kang Pharmaceuticals Co., Ltd. romanized; Shandong Lukang Group Saite Co., Ltd.CDE ↗
Dapoxetine Hydrochloride Tablets CYHS2200338Generic2022/02/17Suzhou Wang Shan Wang Shui Biopharmaceuticals Co., Ltd. romanized; Shandong Lukang Group Saite Co., Ltd.CDE ↗
聚乙二醇4000散 · No verified English name CYHS2100049Generic2021/01/13Guangzhou Shi Ji Pharmaceuticals Technology Co., Ltd. romanized; Shandong Lukang Group Saite Co., Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/17
Chemical-drug catalogue
Last successful update: 2026/11/17
API registrations
Last successful update: 2026/11/17
NMPA drug delivery notices
Last successful update: 2026/11/17

Loaded notices dated 2026-11-03 to 2026-11-17; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.